Status:
COMPLETED
Influence of a PPMTM on Adherence and Clinical Outcomes Among Preterm Infants With Iron Supplementation
Lead Sponsor:
Shaoxing Maternity and Child Health Care Hospital
Conditions:
Preterm Infants
Clinical Outcome
Eligibility:
All Genders
26-32 years
Phase:
NA
Brief Summary
This is a randomised trial on the efficacy of a Pharmacist-led Patient-Centered Medication Therapy Management on clinical outcomes among preterm infants born before 32 weeks gestation with iron supple...
Detailed Description
This is a randomised trial on the efficacy of a Pharmacist-led Patient-Centered Medication Therapy Management on clinical outcomes among preterm infants born before 32 weeks gestation with iron supple...
Eligibility Criteria
Inclusion
- NICU inpatients between 26 and 32 weeks of gestation Infants older than two week of age and Iron dosing will be adjusted for weight at weekly intervals to maintain dosing at 4mg/kg/day.
- Parental permission obtained prior to start of study
Exclusion
- In extremis during consent window (as judged by primary attending provider) Known or suspected genetic disorder Small for gestational age (birth weight below the 10th percentile for gestational age) Unable to return for follow-up evaluation at 6 months of age
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2023
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT04740515
Start Date
February 15 2022
End Date
August 8 2023
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaoxing Maternity and Child Care hospital
Shaoxing, Zhejiang, China, 312000